Clinical trial · Interventional
New Thyroid Fine Needle Aspiration Biopsy Apparatus
New Thyroid Fine Needle Biopsy Apparatus
NCT01512212CI-TRIAL-00006083fnabunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluation of the effectivity of the new thyroid fine needle aspiration biopsy (FNAB) apparatus of which patented from Turkish Patent Institute.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Thyroid Cancer | Malignant Thyroid Gland Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| biopsy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- NO_INTERVENTION
- label
- single group
- description
- FNAB will be perform first with standart technique and after with new FNAB apparatus
- interventionNames
- Procedure: biopsy
Primary outcomes (1)
- measure
- number of cells
- timeFrame
- 2
- description
- number of aspirated cells will be compared
Secondary outcomes (1)
- measure
- type of cells
- timeFrame
- 2
- description
- type (benign, suspect, malign) of cells will be compared
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 17 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * fine needle aspiration biopsy indicated noduler goiter patients Exclusion Criteria: * diffuse goiter
References
Publications (0)
Data not yet available
No reference posted for this study.